CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 400 enrolled
Drug / intervention
high-selenium lentils +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02429921
NCT02429921N/ACompleted

Mitigating Arsenic Toxicity in Bangladeshi People by Supplementing Their Diets With High Selenium Lentils

University of Calgary·interventional·Posted Apr 29, 2015·Updated Mar 31, 2017

In Brief

A clinical study evaluating high-selenium lentils and Low-Se lentils for Arsenic Poisoning. Completed, enrolled 400 participants across 1 site.

Detailed Summary

About 45 million people in Bangladesh are chronically exposed to unacceptable levels of arsenic in their drinking water. Chronic arsenic poisoning leads to cancers, and vascular diseases. This dietary trial intends to test the potential of high-selenium lentils, consumed as lentil soup, in reducing the arsenic body burden in an exposed Bangladeshi population, and in improving the overall health status. Arsenic-exposed families will be assigned to one of two groups. One group will eat lentils (50g/person/day) that are naturally high in selenium, the other group will receive lentils with low selenium content. This 6 months trial is randomized and double-blinded.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesBangladesh

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedApr 29, 2015
Enrollment StartOct 1, 2015
Primary CompletionSep 1, 2016
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 11.2 years ago

Interventions

high-selenium lentilsdietary

lentils grown on naturally selenium-rich soils in the Canadian Prairies

Low-Se lentilsdietary

lentils grown on selenium-deficient soils in Idaho, USA.